Answers are grounded in this paper and cite their sources.
Background Lassa fever (LF) remains a major public health threat in Nigeria, with outcomes influenced by timely diagnosis and treatment and by potential healthcare-associated transmission. We characterised confirmed LF cases and conducted contact investigations at two tertiary hospitals in Rivers State, Nigeria, during the 2024 outbreak. Methods We conducted a descriptive two-centre case series of confirmed LF cases identified at the University of Port Harcourt Teaching Hospital (UPTH) and Rivers State University Teaching Hospital (RSUTH) from January 23 to August 13, 2024. Cases were confirmed by real-time reverse-transcription polymerase chain reaction (RT-PCR) for Lassa virus. Clinical, epidemiological, laboratory, treatment, and outcome data were obtained from hospital and public health records. Contact investigations included risk stratification, 21-day active surveillance, clinical assessment and RT-PCR testing of symptomatic contacts, and ribavirin post-exposure prophylaxis (PEP) for eligible high-risk contacts. Analysis was descriptive. Results Seven laboratory-confirmed cases were identified: five community-associated and two healthcare-associated infections among high-risk healthcare-worker contacts of the UPTH index case. Patients were aged 21–61 years, and four were male. Five patients had gastrointestinal and haemorrhagic manifestations (71.43%), while three had AKI and neurological manifestations (42.86%). Five patients survived, and two died, giving a case fatality proportion of 28.57%. Both deaths occurred in community-associated index cases before therapeutic ribavirin could be administered. Contact surveillance detected the two healthcare-associated infections, which had mild clinical courses. At UPTH, 106 primary contacts were identified; 42 were high-risk, of whom 31 developed acute febrile illness, and two were confirmed with secondary LF. All 42 high-risk contacts received ribavirin PEP. At RSUTH, eight high-risk contacts were monitored; one received PEP, and none developed secondary infection. One survivor with severe renal disease required six haemodialysis sessions and was discharged after 18 days. Conclusions The LF outbreak demonstrated substantial clinical heterogeneity, ranging from mild healthcare-associated infection to severe multisystem disease and death. Contact investigation and prospective surveillance enabled detection of healthcare-associated secondary infections and facilitated targeted PEP. Strengthening early recognition, healthcare-worker protection, laboratory confirmation, contact surveillance, and timely treatment should remain priorities for LF preparedness and outbreak response in Nigeria.
No takes yet. Share an insight, caveat, or question.
Onyeaghala et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: